ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Traditional vs. Graft-Augmented Posterior Colporrhaphy

This study is currently recruiting participants.
Verified by University of California, Irvine, January 2008

Sponsored by: University of California, Irvine
Information provided by: University of California, Irvine
ClinicalTrials.gov Identifier: NCT00581594
  Purpose

Women who undergo posterior colporrhaphy with graft augmentation will have a lower recurrence of their posterior wall defect than women who undergo a traditional posterior colporrhaphy.


Condition Intervention
Pelvic Organ Prolapse
Posterior Vaginal Wall Defects
Procedure: Graft-augmented colporrhaphy
Procedure: Traditional posterior colporrhaphy

MedlinePlus related topics:   Pelvic Support Problems   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Single Blind (Subject), Parallel Assignment
Official Title:   Traditional vs. Graft-Augmented Posterior Colporrhaphy: A Randomized Prospective Study

Further study details as provided by University of California, Irvine:

Primary Outcome Measures:
  • The primary outcome of recurrence of stage II posterior wall defects will be measured using the pelvic organ prolapse quantification exam (POPQ). [ Time Frame: 5 Years ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • The secondary outcomes will be measuring the effects of the surgical repair on various aspects of life using a series of questionnaires: SF-36 as a measure of quality of life, PISQ to measure sexual function, and FISI to measure rectal function. [ Time Frame: 5 Years ] [ Designated as safety issue: No ]

Estimated Enrollment:   128
Study Start Date:   January 2006
Estimated Study Completion Date:   December 2011
Estimated Primary Completion Date:   December 2011 (Final data collection date for primary outcome measure)

Arms Assigned Interventions
1
Posterior repair with graft augmentation.
Procedure: Graft-augmented colporrhaphy
Patients will undergo their randomized surgical procedure. Patients will be seen at 2 weeks for routine post-op care and evaluation of any post-op complications. Patients will be seen at 6 weeks for a pelvic exam and evaluation of the posterior wall. Points Ap and Bp will be recorded with values at 0.5cm intervals being on the posterior vaginal wall that is 3cm above the hymen. Point Bp is the most dependent portion of the posterior vaginal wall when the patient performs a Valsalva maneuver. Patients will next be seen at 6 months, at which time they will undergo a pelvic exam evaluation of posterior wall support and completion of SF-36, PISQ and FISI. They will also be questioned about any defecatory dysfunction, pelvic pain and/or symptoms of prolapse. Questionnaires will take about 60 minutes. Patients will then be seen at 1 year and yearly intervals up to five years to have a pelvic exam for evaluation of posterior wall support as well as all the questionnaires.
2
Posterior repair without graft augmentation.
Procedure: Traditional posterior colporrhaphy
Patients will undergo their randomized surgical procedure. Patients will be seen at 2 weeks for routine post-op care and evaluation of any post-op complications. Patients will be seen at 6 weeks for a pelvic exam and evaluation of the posterior wall. Points Ap and Bp will be recorded with values at 0.5cm intervals being on the posterior vaginal wall that is 3cm above the hymen. Point Bp is the most dependent portion of the posterior vaginal wall when the patient performs a Valsalva maneuver. Patients will next be seen at 6 months, at which time they will undergo a pelvic exam evaluation of posterior wall support and completion of SF-36, PISQ and FISI. They will also be questioned about any defecatory dysfunction, pelvic pain and/or symptoms of prolapse. Questionnaires will take about 60 minutes. Patients will then be seen at 1 year and yearly intervals up to five years to have a pelvic exam for evaluation of posterior wall support as well as all the questionnaires.

Detailed Description:

The traditional approach to surgical repair of posterior wall defect is the posterior colporrhaphy. Although this technique has been successful in the anatomic correction of the defect, the functional outcomes have been disappointing. This fact suggests improvement in the functional and anatomic outcomes following a traditional posterior colporrhaphy. Consequently, the idea of incorporating graft material into the repair to augment the patient's own tissue has been examined. Placing a piece of graft material in between the vagina and rectum adds an extra layer of support and thus augments the strength of the repair. The purpose of this study is to evaluate the anatomic and functional outcomes of posterior compartment, graft-augmented traditional posterior colporrhaphy vs. traditional posterior colporrhaphy alone.

  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • Age > 18 years old
  • Posterior wall defect with point Ap or Bp at 0 or greater
  • Desires surgical correction
  • Willing to accept randomization to graft vs. no graft
  • Competent to sign an informed consent
  • Completed childbearing
  • Non-pregnant

Exclusion Criteria:

  • Current anal sphincter disruption with planned incontinent surgical repairs
  • Poor surgical candidate
  • History of rectal cancer or inflammatory bowel disease
  • Current rectovaginal
  • History of vaginal cancer
  • History of vaginal/pelvic radiation
  • Foreshortened vagina
  • Previous adverse reaction to Xenform matrix graft material
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00581594

Locations
United States, California
University of California, Irvine Medical Center     Recruiting
      Orange, California, United States, 92868
      Contact: Misa Lee     714-456-6846     mlee34@uci.edu    
      Principal Investigator: Karen L Noblett, M.D.            
      Sub-Investigator: Ene G George, M.D.            

Sponsors and Collaborators
University of California, Irvine

Investigators
Principal Investigator:     Karen L Noblett, M.D.     University of California, Irvine Medical Center    
  More Information

Responsible Party:   University of California, Irvine Medical Center ( Karen Noblett, Associate Professor )
Study ID Numbers:   2005-4574
First Received:   December 20, 2007
Last Updated:   January 10, 2008
ClinicalTrials.gov Identifier:   NCT00581594
Health Authority:   United States: Institutional Review Board

Keywords provided by University of California, Irvine:
Pelvic organ prolapse  
Posterior wall defects  
Graft-augmented repair  
Posterior colporrhaphy  

Study placed in the following topic categories:
Pathological Conditions, Anatomical
Digestive System Diseases
Gastrointestinal Diseases
Intestinal Diseases
Rectal Diseases
Prolapse
Rectal Prolapse

ClinicalTrials.gov processed this record on September 05, 2008




Links to all studies - primarily for crawlers